List View List View   Icon View Icon View

Showing items 1 - 7 of 7.

Add to Quick Collection   All 7 Results

  • First
  • Previous
  • 1
  • Next
  • Last
Title Author/Creator Date Full Text Reviewed
Add A methodology for the analysis of PSA response signatures Ebert, Martin A.; Lamb, David S.; Joseph, David J.; Steigler, Allison; Denham, James W. 2011 — Reviewed
Add Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial Capp, Anne; Inostroza-Ponta, Mario; Atkinson, Chris; North, John; Poulsen, Michael... More 2009 — Reviewed
Add Measuring time to biochemical failure in the Trog 96.01 trial: when should the clock start ticking? Denham, James W.; Steigler, Allison; Gleeson, Paul S.; D'Este, Catherine; Kumar, Mahesh... More 2009 — Reviewed
Add PSA response signatures: a powerful new prognostic indicator after radiation for prostate cancer? Denham, James W.; Lamb, David S.; Joseph, David; Matthews, John; Atkinson, Chris... More 2009 — Reviewed
Add Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer Denham, James W.; Kumar, Mahesh; Turner, Sandra; Greer, Peter B.; D'Este, Catherine... More 2009 — Reviewed
Add Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? Denham, James W.; Steigler, Allison; Wilcox, Chantelle; Lamb, David S.; Joseph, David... More 2009 — Reviewed
Add Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial Denham, James W.; Steigler, Allison; Gleeson, Paul S.; Greer, Peter B.; D'Este, Catherine... More 2008 — Reviewed
  • First
  • Previous
  • 1
  • Next
  • Last
Author/Creator
Keyword